LekoskopLekoskop
EN All changes
Medicine recalls and shortages › Drug Safety Update › 15 Jul 2026
Drug Safety Update

Botulinum toxin type A products

Published on 15 Jul 2026 · source: MHRA — Medicines and Healthcare products Regulatory Agency
Cases of iatrogenic botulism have been reported following the therapeutic or cosmetic use of botulinum toxin containing products where the toxin’s effect extends beyond the area of treatment. Patients…
Drug Safety Update on GOV.UK ↗ All events: Botulinum toxin type A products

What this means

Drug Safety Update is the MHRA bulletin for healthcare professionals: new safety information, restrictions of use and recommendations for monitoring.

Summary

Cases of iatrogenic botulism have been reported following the therapeutic or cosmetic use of botulinum toxin containing products where the toxin’s effect extends beyond the area of treatment. Patients should seek immediate medical advice if they experience signs and symptoms.

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.